Factors Associated to Success of Hepatitis C Therapy

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

December 31, 2008

Conditions

Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Interventions

DRUG

pegylated-interferon, conventional-interferon, ribavirin

Genotype 1: pegylated-interferon 2a or 2b plus ribavirin for 48 weeks. Genotype 3: conventional-interferon 2a or 2b plus ribavirin for 24 weeks.

Trial Locations (1)

SAE e Hospital Dia de Aids, Botucatu

All Listed Sponsors

lead

UPECLIN HC FM Botucatu Unesp

OTHER

NCT00514111 - Factors Associated to Success of Hepatitis C Therapy | Biotech Hunter | Biotech Hunter